Abstract:The TP53 gene encodes p53, a transcription factor involved in tumor suppression. However, TP53 also encodes other protein isoforms, some of which can disrupt the tumor suppressor functions of p53 even in the absence of TP53 mutations. In particular, elevated levels of the Δ133 TP53 mRNA are detected in many cancer types and can be associated with poorer disease-free survival. We investigated the mechanisms of action of the two proteins translated from the Δ133 TP53 mRNA: the Δ133p53α and Δ160p53α isoforms, both of which retain the oligomerization domain of p53. We discovered that the Δ133p53α and Δ160p53α isoforms adopt an altered conformation compared to full-length p53, exposing the PAb240 epitope (RHSVVV), which is inaccessible to the PAb240 antibody in the functional conformation of p53 (reactive to PAb1620). The Δ133p53α and/or Δ160p53α isoforms form hetero-oligomers with p53, regulating the stability, the conformation and the transcriptional activity of the p53 hetero-oligomers. Under basal conditions, Δ133p53α and Δ160p53α, in complex with p53, prevent proteasome-dependent degradation leading to the accumulation of PAb240 reactive Δ133p53α/Δ160p53α/p53 hetero-oligomers without increasing p53 transcriptional activity. Conversely, depletion of endogenous Δ133p53α isoforms in human fibroblasts is sufficient to restore p53 transcriptional activity, towards p53-target genes involved in cell cycle arrest. In the DNA damage response (DDR), PAb240 reactive Δ133p53α/Δ160p53α/p53 hetero-oligomers are highly phosphorylated at Ser15 compared to PAb1620-reactive p53 complexes devoid of Δ133p53α and Δ160p53α. This suggests that PAb240-reactive p53 hetero-oligomers integrate DNA damage signals. Δ133p53α accumulation is a late event in the DDR that depends on p53, but not on its transcriptional activation. The formation of Δ133p53α and p53 complexes increases at later DDR stages. We propose that Δ133p53α isoforms regulate p53 conformation as part of the normal p53 biology, modulating p53 activity and thereby adapting the cellular response to the cell signals.

[The Molecular Interaction Between P53 and Telomeric Repeat Binding Protein 1 in Vitro].

In Vitro Binding of P53 and Telomeric Repeat Factor 2

Interaction Between P53 and TRF1、TRF2 and Analysis of Binding Domain of P53 in vitro

Abstract 2988: Loss of Rbm38 Cooperates with Mutant P53 to Promote Lymphomagenesis Through Downregulation of Pten

Novel Roles For P53 In The Genesis And Targeting Of Tetraploid Cancer Cells

Role of p53 transcription factor in determining the efficacy of telomerase inhibitors in cancer treatment

The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.

Conformational Stability and Dynamics of the Cancer‐associated Isoform Δ133p53β Are Modulated by P53 Peptides and P53‐specific DNA

The Putative Tumor Suppressor C53 Interacts with the Human Telomerase Reverse Transcriptase Htert and Regulates Telomerase Activity

Interaction of p53 with the Δ133p53α and Δ160p53α isoforms regulates p53 conformation and transcriptional activity

Interaction Between P53 N Terminus and Core Domain Regulates Specific and Nonspecific DNA Binding.

Molecular dynamics-based computational investigations on the influence of tumor suppressor p53 binding protein against other proteins/peptides

The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl.

A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins

The DNA-binding and Transcription-Activation Abilities of P53 Are Necessary but Not Sufficient for Its Antiproliferation Function.

P53 Suppresses Hyper-Recombination by Modulating BRCA1 Function.

Expression, purification, and in vitro mitochondrial interaction analysis of full-length and truncated human tumor suppresser p53

POT1 and TRF2 Cooperate To Maintain Telomeric Integrity

DNA Strand Break-Sensing Molecule Poly(ADP-Ribose) Polymerase Cooperates with P53 in Telomere Function, Chromosome Stability, and Tumor Suppression

The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-Ribose

Inhibition of telomerase activity in salivary adenoid cystic carcinoma cells by P53